|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/46 | (2006.01) | ||
| C07K 16/30 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3330293 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17206868.6 |
| Date of filing the European patent application | 2009-11-06 | |
| (97) | Date of publication of the European application | 2018-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-24 |
| (46) | Date of publication of the claims translation | 2019-10-10 |
| (30) | Number | Date | Country code |
| 112323 P | 2008-11-07 | US | |
| 183291 P | 2009-06-02 | US | |
| 221269 P | 2009-06-29 | US |
| (72) |
ZUGMAIER, Gerhard, DE
|
| (73) |
Amgen Research (Munich) GmbH,
Staffelseestrasse 2, 81477 München,
DE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Vaikų ūminės limfoblastinės leukemijos gydymas bispecifiniais antikūnais prieš CD3XCD19 |
| TREATMENT OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH BISPECIFIC ANTIBODIES AGAINST CD3XCD19 |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 17 | 347.00 EUR |
| 2026-11-06 |